Jump to content

Finch and Takeda Pharmaceutical

Recommended Posts


"Finch and Takeda pharmaceutical inked a global collaboration deal to jointly develop FIN-524.  FIN-524 is a live biotherapeutic product made up of cultured bacteria strains that have been associated with positive clinical outcomes in irritable bowel disease (IBD). 



Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...